DRIO - Company ID 0001533998
The table below shows DarioHealth Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $5.58M | $5.01M | $5.37M | $6.75M | $7.42M | $6.25M |
| Cost of revenue | $2.38M | $1.99M | $2.40M | $2.87M | $3.55M | $3.50M |
| Gross profit | $3.20M | $3.02M | $2.96M | $3.88M | $3.88M | $2.76M |
| R&D | $2.38M | $3.33M | $3.72M | $4.11M | $5.45M | $6.81M |
DarioHealth Corp. reported annual revenue of $22.36M for fiscal year 2025. That is down 17.3% from $27.04M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.80M (FY 2016) to $22.36M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $3.23M | $4.57M | $3.21M | $3.31M | $3.73M | $5.00M |
| Operating income | -$7.31M | -$9.48M | -$9.20M | -$9.41M | -$12.03M | -$16.19M |
| Income tax | $57.00K | $0.00 | - | $22.00K | -$13.00K | - |
| Net income | -$8.25M | -$10.47M | -$12.99M | -$9.23M | -$12.33M | -$13.61M |
| EPS (diluted) | $1.25 | $2.96 | $0.18 | $2.87 | $4.91 | $0.08 |